Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2018 Mar 12;115(12):E2899. doi: 10.1073/pnas.1803199115

Correction for Kudalkar et al., From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

PMCID: PMC5866622  PMID: 29531046

PHARMACOLOGY Correction for “From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection,” by Shalley N. Kudalkar, Jagadish Beloor, Elias Quijano, Krasimir A. Spasov, Won-Gil Lee, José A. Cisneros, W. Mark Saltzman, Priti Kumar, William L. Jorgensen, and Karen S. Anderson, which was first published December 26, 2017; 10.1073/pnas.1717932115 (Proc Natl Acad Sci USA 115:E802–E811).

The authors would like to note that the conflict of interest statement should state, “W.L.J. and K.S.A. are listed as the inventors on a patent issued to Yale University on the intellectual property associated with compound I [US Patent 9,382,245 (2016)].”


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES